SGLT2 Inhibitors: A Broad Impact Therapeutic Option for the Nephrologist

Since their introduction as antidiabetic drugs, SGLT2 inhibitors (SGLT2i) have come a long way, proving to be beneficial on cardiovascular and renal outcomes independently of diabetes status. The benefits go far beyond glycemic control, and both the cardio- and nephroprotection are underpinned by di...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Antonio, Pesce, Francesco, Iacoviello, Massimo, Anzaldi, Massimiliano, Amico, Francesco, Catalano, Maria, Leonardi, Giuseppe, Gatta, Carmela, Costanza, Giusy, Corrao, Salvatore, Gesualdo, Loreto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479658/
https://www.ncbi.nlm.nih.gov/pubmed/37674992
http://dx.doi.org/10.3389/fneph.2022.867075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479658/
https://www.ncbi.nlm.nih.gov/pubmed/37674992
http://dx.doi.org/10.3389/fneph.2022.867075

Ejemplares similares